Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person1
Accent Marketing & Research Limited
Company · 02231083
Primary record20
Bowman Consulting Group Ltd. filed 8-K
Item 1.02 Termination of a Material Definitive Agreement. On the Closing Date, in connection with the closing of the Merger, the Company repaid all loans, terminated all credit commitments and released all liens and secu
Quoin Pharmaceuticals Ltd. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On November 4, 2026, Quoin Pharmaceuticals Ltd. (the “Company” or “Quoin”) entered into a sales agreement (the “Sales Agreement”) with Leerink Partners LLC (“Leerink
ARCH CAPITAL GROUP LTD. filed 8-K
ITEM 1.01 Entry into a Material Definitive Agreement. On October 28, 2026, Arch Reinsurance Ltd. (“ArchRe”), a wholly-owned subsidiary of Arch Capital Group Ltd. (“Arch”), entered into Amendment No. 6 to Letter of Credit
BrightSpire Capital, Inc. filed 8-K
Item 1.01 Entry Into a Material Definitive Agreement. 2026-FL4 CLO Transaction Overview On October 16, 2026 (the “CLO Closing Date”), BrightSpire Capital, Inc. (the “Company”) entered into a collateralized loan obligatio
BioAtla, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On October 15, 2026 (the “Effective Date”), BioAtla, Inc. (the “Company”) entered into the Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, Ltd., a Cayma
Cambium Networks Corp filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on September 14, 2026, Cambium Networks, Ltd (“CNL”), an indirect, wholly-owned subsidiary of Cambium Networks Corporation (the “Company”), e
CURIS INC filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement On October 16, 2026, Curis, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purcha
CRESCENT BIOPHARMA, INC. filed 8-K
Item 8.01 Other Events. On October 15, 2026, Crescent Biopharma, Inc. ( Crescent or the Company ) issued a press release announcing clinical pipeline updates, including (i) enrolling patients in cohorts combining CR-001,
Quantumsphere Acquisition Corp filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On October 9, 2026, Quantumsphere Acquisition Corporation, a Cayman Islands exempted company ( QUMS or Parent ), Fortune Favor Technology Inc., a Cayman Islands exem
CDT Equity Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Senior Secured Convertible Promissory Note to J.J. Astor & Co. On October 6, 2026, CDT Equity Inc. (the Company ) issued a senior secured convertible note (the Note )
Marwynn Holdings, Inc. filed 8-K
Item 8.01. Other Events. On October 8, 2026, Marwynn Holdings, Inc. (the Company ) entered into a memorandum of understanding (the MOU ) with OmniX Technologies Pte. Ltd., a Singapore private company limited by shares (U
ESCO TECHNOLOGIES INC filed SCHEDULE 13D
(the "SEC") and relates to the shares of Common Stock, par value $0.01 per share ("Common Stock"), of ESCO Technologies Inc., a Missouri corporation (the "Issuer"), and the other matters specifically set forth herein. Th
TaoWeave, Inc. filed 8-K
Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2026 TAOWEAVE, INC. (Exact name of regist
Innventure, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On October 6, 2026, Innventure, Inc. (the Company ) entered into an At The Market Offering Agreement (the Agreement ) with Lucid Capital Markets, LLC ( Lucid ). Pursu
TPG RE Finance Trust, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. CLO Transaction Overview On October 2, 2026 (the FL8 CLO Closing Date ), TPG RE Finance Trust, Inc. (the Company ) entered into a collateralized loan obligation ( TRT
insider_trade
National Storage Mechanism | Additional information RNS Number : 5827X Wellnex Life Limited 05 October 2026 ASX/AIM Announcement 5 October 2026 Director’s dealing Wellnex Life Limited (ASX/AIM: WNX) (" Wellnex Life " or
Hall Chadwick Acquisition Corp filed 8-K
Item 1.01 Entry Into a Material Definitive Agreement. As previously announced, on May 31, 2026, Hall Chadwick Acquisition Corp. (the Company ), entered into a Business Combination Agreement (the Business Combination Agre
Thunder Bridge Capital Partners V, Ltd. filed 8-K
Item 8.01. Other Events. Separate Trading of Units, Class A Ordinary Shares and Warrants On October 2, 2026, Thunder Bridge Capital Partners V, Ltd. (the Company ) issued a press release, a copy of which is attached as E
FLEX LTD. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 29, 2026 (the Closing Date ), Flex Ltd. (the Company or Flex ) entered into a Credit Agreement (the Credit Agreement ), by and among the Company, as borr
Homes England (the name adopted by the Homes and Communities Agency) awarded £53,840 to Savills (UK) Ltd
Homes England (the name adopted by the Homes and Communities Agency) awarded a contract to Savills (UK) Ltd worth £53,840 on 2026-06-11. Contract: Homes England - Property and Financial Professional Services - Disposal o